Two boys died after a gene therapy. This family won’t give up hope

washingtonpost.com/business/2025/07/26/fda-rare-disease-sarepta-duchenne

The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients died, the drug’s manufacturer halted dosing under pressure from the FDA.

This story appeared on washingtonpost.com, 2025-07-26 11:00:03.
The Entire Business World on a Single Page. Free to Use →